The Max Foundation Creates Subsidiary Organization, MaxAid, to Further Mission

Now in its 20th year, The Max Foundation is undergoing exciting strategic changes aimed at strengthening organizational efforts to improve global access to cancer treatment, care and support. To that end, we announce the launch of MaxAid, a subsidiary organization set up by The Max Foundation to further its mission. MaxAid is a Washington nonprofit corporation with its own IRS determination letter of 501(c)(3) public charity status.

From its launch, MaxAid will host our collaboration with Novartis, a leading global healthcare company, around humanitarian access to their medicines Glivec® and Tasigna® in a joint initiative. In the future similar contributions from other partnering companies may also be received by MaxAid.

“The advent of MaxAid is exciting for The Max Foundation because it enables us to take our operational work to the next level,” says Paula Boultbee, Chair of the Board for The Max Foundation.  She continues, “By launching MaxAid, we accomplish yet another strategic milestone for The Max Foundation in our role as a bridge to access for people facing cancer currently without treatment in lower resource settings around the world.”

This positive step of launching MaxAid in 2017 promises to keep us well positioned to decrease avoidable cancer deaths in the least developed countries and help people around the world to face cancer with dignity and hope.

See All News

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • The Max Foundation Releases Video from Global Experience

    The Max Foundation Releases Video from Global Experience

    Watch The Max Foundation’s video from Max Global Experience Uganda. The Max Global Experience Uganda was a fundraising and engagement opportunity for patient leaders, industry partners, and Max team members to come together to expand access to cancer treatment in Africa. The global experience included an all-day symposium, a visit to the Uganda Cancer Institute, and a “last mile” walk along the Nile in solidarity with patients across Africa.

  • The Max Foundation and International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Partner to Enhance the Care of CLL in Low- and Middle-Income Countries

    The Max Foundation and International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Partner to Enhance the Care of CLL in Low- and Middle-Income Countries

    iwCLL to provide training, medical, and programmatic guidance to support implementation of access program for innovative CLL therapy in 29 LMICs over the next three years SEATTLE, Washington – October 10, 2023 – The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients….

  • Novartis, The Max Foundation, and a young girl who dreamed to be a lawyer

    Novartis, The Max Foundation, and a young girl who dreamed to be a lawyer

    The Max Foundation and Novartis renew their commitment to CML patients